Switzerland became a Gavi donor in December 2016, with a contribution of 2 million Swiss francs in support of Gavi’s core programmes in 2016–2020. During Gavi’s Global Vaccine Summit 2020 replenishment conference, Switzerland announced a scale-up in its contribution, with a new commitment of 11 million Swiss francs for Gavi’s core programmes in 2021–2025 (totalling US$ 14 million).

In response to the COVID-19 pandemic, Switzerland significantly stepped up its commitment to Gavi by contributing 145 million Swiss francs (US$ 157 million) to the Gavi COVAX AMC and made COVID-19 vaccine doses available to lower-income countries via the COVAX dose sharing mechanism. 

Proceeds to Gavi 6.0 as of 30 June 2026†
Contributions to Gavi Board approved financing instruments

*Local currency

†Proceeds are the funds that Gavi receives from donor commitments, either through direct donor payments, funding raised in advance against future donor pledges through IFFIm, or AMC funds released by the World Bank.

Contributions and pledges per strategic period (US$ millions)

Hover over the bar chart above to view the data

Direct Contributions (including Matching Fund)

Non-US$ contributions are converted to US$ as follows:

  • Before Gavi 6.0 (2000–2025): exchange rate on date of receipt; where hedged (2014–2025), the hedge rate applies instead.
  • Gavi 6.0 (2026 onward, received & future contributions and Matching Fund Pledges): Bloomberg replenishment rate, 16:00 London time, 25 June 2025.

IFFIm Contributions

Non-US$ contributions are converted to US$ as follows:

  • Received Contributions: rate confirmed by the World Bank's International Bank for Reconstruction and Development (IBRD).
  • Future, signed contribution agreements: exchange rate at time of signing.
  • Future, unsigned contribution agreements: Bloomberg replenishment rate, 16:00 London time, 25 June 2025.

 

All donors